ClinicalTrials.Veeva

Menu
N

North Carolina Clinical Research | Raleigh, NC

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

azelastine hydrochloride
fluticasone propionate
SUN-101
Fluticasone Propionate
Olodaterol
RN316
PF-04950615
Ciclesonide
azelastine Hcl
HFA

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 61 total trials

A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it)

This study is to evaluate the Pharmacodynamic (PD), safety, tolerability, Pharmacokinetic (PK), and plasma biomarker response of KAN-101 in participa...

Enrolling
Celiac Disease
Drug: Cohort 2 in Part A
Drug: Group 4 in Part B and Part C

This study is to characterize the safety and tolerability of an investigational drug called DONQ52 and consists of a single ascending dose part (Part...

Active, not recruiting
Celiac Disease
Drug: Placebo
Drug: DONQ52

Trial sponsors

Meda Pharmaceuticals logo
Sumitomo Pharma logo
Pfizer logo
Sunovion logo
Novartis logo
Penn State Health logo
Boehringer Ingelheim logo
C
K
MedImmune logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems